{"transactions":[{"id":748750,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:08:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":214357,"source":{"system":"sec-edgar","filing":"0001193125-26-260257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260257/ownership.xml","form_type":"4"}},{"id":928255,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T01:04:03.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001193125-26-029893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029893/ownership.xml","form_type":"4"}},{"id":928254,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:04:03.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":6494,"price":22.17,"value":143971.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer."}],"balance_after":197482,"source":{"system":"sec-edgar","filing":"0001193125-26-029893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029893/ownership.xml","form_type":"4"}},{"id":928253,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:04:03.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":203976,"source":{"system":"sec-edgar","filing":"0001193125-26-029893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029893/ownership.xml","form_type":"4"}},{"id":1066403,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T17:17:32.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29806,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to the Merger, the shares were held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-021950","document":"form4-08142025_090828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925021950/form4-08142025_090828.xml","form_type":"4"}},{"id":1066402,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T17:17:32.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29807,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the Merger, the shares were held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-021950","document":"form4-08142025_090828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925021950/form4-08142025_090828.xml","form_type":"4"}},{"id":1066401,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T17:17:32.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":330700,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Prior to the Merger, the shares were held in the name of KBW 2005 Trust for which Reporting Person is the Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-021950","document":"form4-08142025_090828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925021950/form4-08142025_090828.xml","form_type":"4"}},{"id":1066400,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T17:17:32.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22222,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the \"Company\"), Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), on August 14, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a \"CVR\") subject to the terms and conditions of a Contingent Value Rights Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-021950","document":"form4-08142025_090828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925021950/form4-08142025_090828.xml","form_type":"4"}},{"id":1095109,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T18:51:03.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":1471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001415889-25-019152","document":"form4-07022025_100759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925019152/form4-07022025_100759.xml","form_type":"4"}},{"id":1103612,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T22:42:57.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":28609,"price":6.47,"value":185100.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders"}],"balance_after":212771,"source":{"system":"sec-edgar","filing":"0001376339-25-000072","document":"wk-form4_1750718569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633925000072/wk-form4_1750718569.xml","form_type":"4"}},{"id":1183347,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T19:00:38.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":1471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":20751,"source":{"system":"sec-edgar","filing":"0001415889-25-009777","document":"form4-04022025_110435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925009777/form4-04022025_110435.xml","form_type":"4"}},{"id":1213587,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-12T00:00:02.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037511/ownership.xml","form_type":"4"}},{"id":1213586,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:02.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":193476,"source":{"system":"sec-edgar","filing":"0000950170-25-037511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037511/ownership.xml","form_type":"4"}},{"id":1314640,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T17:54:02.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":3078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":19280,"source":{"system":"sec-edgar","filing":"0001415889-25-000608","document":"form4-01032025_100158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925000608/form4-01032025_100158.xml","form_type":"4"}},{"id":1394397,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T19:58:09.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":3078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":16202,"source":{"system":"sec-edgar","filing":"0001415889-24-024533","document":"form4-10022024_111005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924024533/form4-10022024_111005.xml","form_type":"4"}},{"id":1414664,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-06T00:00:02.000Z","date":"2024-09-04","kind":"gift","planned":false,"acquired":false,"shares":746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a charitable gift by the Reporting Person."}],"balance_after":191093,"source":{"system":"sec-edgar","filing":"0000950170-24-104194","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024104194/ownership.xml","form_type":"4"}},{"id":1458547,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-09T00:00:03.000Z","date":"2024-07-03","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2025-02-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-082240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024082240/ownership.xml","form_type":"4"}},{"id":1458546,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-09T00:00:03.000Z","date":"2024-07-03","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":13.9,"value":208500.0,"ownership":{"direct":true},"balance_after":191839,"source":{"system":"sec-edgar","filing":"0000950170-24-082240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024082240/ownership.xml","form_type":"4"}},{"id":1462936,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T20:06:20.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":3078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":13124,"source":{"system":"sec-edgar","filing":"0001415889-24-019056","document":"form4-07032024_120717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924019056/form4-07032024_120717.xml","form_type":"4"}},{"id":1488246,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:18:49.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":23190,"price":7.26,"value":168359.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":184162,"source":{"system":"sec-edgar","filing":"0001376339-24-000047","document":"wk-form4_1717705117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633924000047/wk-form4_1717705117.xml","form_type":"4"}},{"id":1553469,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T18:22:53.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":3078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":10046,"source":{"system":"sec-edgar","filing":"0001415889-24-009849","document":"form4-04022024_100447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924009849/form4-04022024_100447.xml","form_type":"4"}},{"id":1576651,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-14T17:50:25.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the shares subject to the option shall vest each month following the Issuer's 2024 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":29400,"derivative":{"exercise_price":9.95,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":29400},"source":{"system":"sec-edgar","filing":"0001415889-24-008027","document":"form4-03142024_090318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924008027/form4-03142024_090318.xml","form_type":"4"}},{"id":1599790,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3679,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0000950170-24-026618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026618/ownership.xml","form_type":"4"}},{"id":1599789,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025."}],"balance_after":176839,"source":{"system":"sec-edgar","filing":"0000950170-24-026618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026618/ownership.xml","form_type":"4"}},{"id":1692304,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T18:14:52.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":6968,"source":{"system":"sec-edgar","filing":"0001209191-24-000520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919124000520/doc4.xml","form_type":"4"}},{"id":1749100,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T13:00:07.000Z","date":"2023-11-03","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":29.03,"exercise_date":"2015-02-28","expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-054440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054440/doc4.xml","form_type":"4"}},{"id":1749099,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-06T13:00:07.000Z","date":"2023-11-03","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":29.03,"value":435450.0,"ownership":{"direct":true},"balance_after":174993,"source":{"system":"sec-edgar","filing":"0001209191-23-054440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123054440/doc4.xml","form_type":"4"}},{"id":1767383,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T19:50:25.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":6168,"source":{"system":"sec-edgar","filing":"0001209191-23-051739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123051739/doc4.xml","form_type":"4"}},{"id":1836097,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T21:05:47.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":5368,"source":{"system":"sec-edgar","filing":"0001209191-23-041386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123041386/doc4.xml","form_type":"4"}},{"id":1842659,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T19:34:40.000Z","date":"2023-06-26","kind":"purchase","planned":false,"acquired":true,"shares":112500,"price":8,"value":900000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee."}],"balance_after":330700,"source":{"system":"sec-edgar","filing":"0001209191-23-040091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123040091/doc4.xml","form_type":"4"}},{"id":1854142,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T22:20:14.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":35354,"price":4.95,"value":175002.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":160972,"source":{"system":"sec-edgar","filing":"0001376339-23-000041","document":"wk-form4_1686867605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000041/wk-form4_1686867605.xml","form_type":"4"}},{"id":1923704,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-06T21:36:40.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the shares subject to the option shall vest each month following the Issuer's 2023 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":15500,"derivative":{"exercise_price":12.86,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001209191-23-023694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123023694/doc4.xml","form_type":"4"}},{"id":1928081,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T18:55:39.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":4568,"source":{"system":"sec-edgar","filing":"0001209191-23-022973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123022973/doc4.xml","form_type":"4"}},{"id":1964297,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:53.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3257,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001209191-23-017402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017402/doc4.xml","form_type":"4"}},{"id":1964296,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:00:53.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":1523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024."}],"balance_after":159993,"source":{"system":"sec-edgar","filing":"0001209191-23-017402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017402/doc4.xml","form_type":"4"}},{"id":2067515,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T17:09:57.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":3768,"source":{"system":"sec-edgar","filing":"0001209191-23-001103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123001103/doc4.xml","form_type":"4"}},{"id":2079156,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-21T14:05:10.000Z","date":"2022-12-19","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":34.92,"exercise_date":"2014-06-04","expiration_date":"2023-06-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-062287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122062287/doc4.xml","form_type":"4"}},{"id":2079155,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-21T14:05:10.000Z","date":"2022-12-19","kind":"exercise","acquired":true,"shares":20000,"price":34.92,"value":698400.0,"ownership":{"direct":true},"balance_after":158470,"source":{"system":"sec-edgar","filing":"0001209191-22-062287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122062287/doc4.xml","form_type":"4"}},{"id":2119978,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T17:10:36.000Z","date":"2022-11-08","kind":"purchase","acquired":true,"shares":60000,"price":17.1425,"value":1028550.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $16.94 to $17.25. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee."}],"balance_after":218200,"source":{"system":"sec-edgar","filing":"0001209191-22-056423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122056423/doc4.xml","form_type":"4"}},{"id":2147260,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-03T20:12:52.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":3394,"source":{"system":"sec-edgar","filing":"0001209191-22-051985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122051985/doc4.xml","form_type":"4"}},{"id":2214632,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-05T18:14:18.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":3020,"source":{"system":"sec-edgar","filing":"0001209191-22-040886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122040886/doc4.xml","form_type":"4"}},{"id":2233937,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:28:15.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":44191,"price":3.96,"value":174996.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":125618,"source":{"system":"sec-edgar","filing":"0001376339-22-000089","document":"wf-form4_165515928060630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000089/wf-form4_165515928060630.xml","form_type":"4"}},{"id":2308190,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:10:01.000Z","date":"2022-04-01","kind":"purchase","acquired":true,"shares":8695,"price":23,"value":199985.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":29806,"source":{"system":"sec-edgar","filing":"0001209191-22-022716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122022716/doc4.xml","form_type":"4"}},{"id":2308189,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:10:01.000Z","date":"2022-04-01","kind":"purchase","acquired":true,"shares":8696,"price":23,"value":200008.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":29807,"source":{"system":"sec-edgar","filing":"0001209191-22-022716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122022716/doc4.xml","form_type":"4"}},{"id":2308188,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:10:01.000Z","date":"2022-04-01","kind":"purchase","acquired":true,"shares":43478,"price":23,"value":999994.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee."}],"balance_after":158200,"source":{"system":"sec-edgar","filing":"0001209191-22-022716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122022716/doc4.xml","form_type":"4"}},{"id":2308187,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:10:01.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":2646,"source":{"system":"sec-edgar","filing":"0001209191-22-022716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122022716/doc4.xml","form_type":"4"}},{"id":2333197,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-15T20:55:47.000Z","date":"2022-03-12","kind":"grant","acquired":true,"shares":29497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the shares subject to the option shall vest each month following the Issuer's 2022 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":29497,"derivative":{"exercise_price":17.11,"expiration_date":"2032-03-12","underlying":"Common Stock","underlying_shares":29497},"source":{"system":"sec-edgar","filing":"0001209191-22-019015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122019015/doc4.xml","form_type":"4"}},{"id":2345778,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T01:04:29.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":5077,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5077,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":5077},"source":{"system":"sec-edgar","filing":"0001209191-22-017349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017349/doc4.xml","form_type":"4"}},{"id":2345777,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T01:04:29.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":2953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023."}],"balance_after":138470,"source":{"system":"sec-edgar","filing":"0001209191-22-017349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017349/doc4.xml","form_type":"4"}},{"id":2449100,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:04:38.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":2272,"source":{"system":"sec-edgar","filing":"0001209191-22-001216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122001216/doc4.xml","form_type":"4"}},{"id":2470734,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-17T01:00:30.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.08,"exercise_date":"2013-08-23","expiration_date":"2022-08-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-070084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121070084/doc4.xml","form_type":"4"}},{"id":2470733,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-17T01:00:30.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":5000,"price":10.08,"value":50400.0,"ownership":{"direct":true},"balance_after":135517,"source":{"system":"sec-edgar","filing":"0001209191-21-070084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121070084/doc4.xml","form_type":"4"}},{"id":2552005,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T21:36:09.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":2061,"source":{"system":"sec-edgar","filing":"0001209191-21-059184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121059184/doc4.xml","form_type":"4"}},{"id":2644639,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:04:42.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to an internal review, the number of shares beneficially owned has been adjusted to correct the number of shares owned directly as compared to the number of shares held by the KBW 2005 Trust for which Reporting Person is Trustee (the \"KBW 2005 Trust\"). Other than the acquisition of restricted stock units reported in this Form 4, the total number of shares held by the Reporting Person has not changed."}],"balance_after":1850,"source":{"system":"sec-edgar","filing":"0001209191-21-045193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121045193/doc4.xml","form_type":"4"}},{"id":2691052,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T18:24:43.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":17056,"price":10.26,"value":174994.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents annual restricted stock grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":81427,"source":{"system":"sec-edgar","filing":"0001376339-21-000073","document":"wf-form4_162222625342159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633921000073/wf-form4_162222625342159.xml","form_type":"4"}},{"id":2761239,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T18:37:13.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":94139,"source":{"system":"sec-edgar","filing":"0001209191-21-024793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121024793/doc4.xml","form_type":"4"}},{"id":2798057,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-11T01:04:03.000Z","date":"2021-03-10","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":42.3,"exercise_date":"2012-06-21","expiration_date":"2021-06-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-019671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019671/doc4.xml","form_type":"4"}},{"id":2798056,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T01:04:03.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":5000,"price":85.76,"value":428800.0,"ownership":{"direct":true},"balance_after":130517,"source":{"system":"sec-edgar","filing":"0001209191-21-019671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019671/doc4.xml","form_type":"4"}},{"id":2798055,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T01:04:03.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":5000,"price":42.3,"value":211500.0,"ownership":{"direct":true},"balance_after":135517,"source":{"system":"sec-edgar","filing":"0001209191-21-019671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019671/doc4.xml","form_type":"4"}},{"id":2807347,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:00:51.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":5518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5518,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":5518},"source":{"system":"sec-edgar","filing":"0001209191-21-018412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018412/doc4.xml","form_type":"4"}},{"id":2807346,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-06T01:00:51.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a correction in the number of shares of common stock reported as beneficially owned by the Reporting Person in prior reports due to an inadvertent error that appeared in the prior reports (an addition of 49 shares)."}],"balance_after":130517,"source":{"system":"sec-edgar","filing":"0001209191-21-018412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018412/doc4.xml","form_type":"4"}},{"id":2839274,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-23T21:29:10.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":6423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the shares subject to the option shall vest each month following the Issuer's 2021 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":6423,"derivative":{"exercise_price":91.5,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":6423},"source":{"system":"sec-edgar","filing":"0001209191-21-013585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121013585/doc4.xml","form_type":"4"}},{"id":2920408,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T20:40:09.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":93928,"source":{"system":"sec-edgar","filing":"0001209191-21-001699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121001699/doc4.xml","form_type":"4"}},{"id":2944434,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T20:28:11.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":11111,"price":90,"value":999990.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":21111,"source":{"system":"sec-edgar","filing":"0001209191-20-063644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120063644/doc4.xml","form_type":"4"}},{"id":2944433,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T20:28:11.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":11111,"price":90,"value":999990.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":21111,"source":{"system":"sec-edgar","filing":"0001209191-20-063644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120063644/doc4.xml","form_type":"4"}},{"id":2944432,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T20:28:11.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":22222,"price":90,"value":1999980.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased pursuant to an underwritten public offering of the Issuer's securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee."}],"balance_after":22222,"source":{"system":"sec-edgar","filing":"0001209191-20-063644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120063644/doc4.xml","form_type":"4"}},{"id":3012961,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:09:18.000Z","date":"2020-10-02","kind":"grant","acquired":true,"shares":26236,"price":6.67,"value":174994.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant to non-employee directors.  Grant is exempt under Rule 16b-3.  Award vests after 12 months."}],"balance_after":64371,"source":{"system":"sec-edgar","filing":"0001376339-20-000123","document":"wf-form4_160192852097584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633920000123/wf-form4_160192852097584.xml","form_type":"4"}},{"id":3013232,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T19:29:05.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":93571,"source":{"system":"sec-edgar","filing":"0001209191-20-053897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120053897/doc4.xml","form_type":"4"}},{"id":3032314,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":1570,"price":64.7955,"value":101728.935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $64.475 to $65.245 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":93214,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032313,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":3351,"price":63.5762,"value":213043.8462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $63.3625 to $64.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":91644,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032312,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":2791,"price":63.0611,"value":176003.5301,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $62.36 to $63.355 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":88293,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032311,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":4336,"price":61.8044,"value":267983.8784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $61.32 to $62.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":85502,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032310,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":5033,"price":60.8648,"value":306332.5384,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $60.28 to $61.27 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":81166,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032309,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":4442,"price":59.646,"value":264947.532,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $59.27 to $60.205 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":76133,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032308,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":5132,"price":58.7512,"value":301511.1584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $58.25 to $59.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":71691,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032307,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":2367,"price":57.7488,"value":136691.4096,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $57.24 to $58.235 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":66559,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3032306,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T20:43:12.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":978,"price":56.406,"value":55165.068,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $56.00 to $56.985 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":64192,"source":{"system":"sec-edgar","filing":"0001209191-20-050353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120050353/doc4.xml","form_type":"4"}},{"id":3065785,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-06T20:33:41.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":38135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3."}],"balance_after":38135,"source":{"system":"sec-edgar","filing":"0001376339-20-000086","document":"wf-form4_159674597890737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633920000086/wf-form4_159674597890737.xml","form_type":"4"}},{"id":3088785,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-06T19:31:01.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":63214,"source":{"system":"sec-edgar","filing":"0001209191-20-041279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120041279/doc4.xml","form_type":"4"}},{"id":3183274,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T19:32:59.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":62857,"source":{"system":"sec-edgar","filing":"0001209191-20-023472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120023472/doc4.xml","form_type":"4"}},{"id":3242229,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:03:33.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3685,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3685,"derivative":{"exercise_price":114.47,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3685},"source":{"system":"sec-edgar","filing":"0001209191-20-014231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014231/doc4.xml","form_type":"4"}},{"id":3242228,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:03:33.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."}],"balance_after":127742,"source":{"system":"sec-edgar","filing":"0001209191-20-014231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014231/doc4.xml","form_type":"4"}},{"id":3284480,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T17:43:48.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the shares subject to the option shall vest each month following the Issuer's 2020 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":40.27,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-007604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120007604/doc4.xml","form_type":"4"}},{"id":3345242,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:04:56.000Z","date":"2019-12-09","kind":"purchase","acquired":true,"shares":4503,"price":25.6095,"value":115319.5785,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $25.37 to $26.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-060106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/doc4.xml","form_type":"4"}},{"id":3345241,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:04:56.000Z","date":"2019-12-09","kind":"purchase","acquired":true,"shares":5497,"price":24.2566,"value":133338.5302,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $23.975 to $24.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":5497,"source":{"system":"sec-edgar","filing":"0001209191-19-060106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/doc4.xml","form_type":"4"}},{"id":3345240,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:04:56.000Z","date":"2019-12-09","kind":"purchase","acquired":true,"shares":4503,"price":25.6095,"value":115319.5785,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $25.37 to $26.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-060106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/doc4.xml","form_type":"4"}},{"id":3345239,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:04:56.000Z","date":"2019-12-09","kind":"purchase","acquired":true,"shares":5497,"price":24.2566,"value":133338.5302,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $23.975 to $24.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee."}],"balance_after":5497,"source":{"system":"sec-edgar","filing":"0001209191-19-060106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919119060106/doc4.xml","form_type":"4"}},{"id":3408975,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-20T21:06:56.000Z","date":"2019-09-18","kind":"purchase","acquired":true,"shares":62500,"price":16,"value":1000000.0,"ownership":{"direct":true},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001209191-19-050408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919119050408/doc4.xml","form_type":"4"}},{"id":3409868,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-19T21:23:55.000Z","date":"2019-09-17","kind":"grant","acquired":true,"shares":12100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option shall vest on September 17, 2020 and an additional 1/36 of the shares subject to the option shall vest monthly thereafter subject to Reporting Person remaining a service provider through each such date."}],"balance_after":12100,"derivative":{"exercise_price":16,"expiration_date":"2029-09-17","underlying":"Common Stock","underlying_shares":12100},"source":{"system":"sec-edgar","filing":"0001209191-19-050253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919119050253/doc4.xml","form_type":"4"}},{"id":3420999,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-06T18:13:14.000Z","date":"2019-09-05","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option to buy shares is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.8,"expiration_date":"2020-06-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-048702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119048702/doc4.xml","form_type":"4"}},{"id":3420998,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-06T18:13:14.000Z","date":"2019-09-06","kind":"purchase","acquired":true,"shares":2500,"price":87.98,"value":219950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in multiple transactions at prices ranging from $87.94 to $88.00, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":125667,"source":{"system":"sec-edgar","filing":"0001209191-19-048702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119048702/doc4.xml","form_type":"4"}},{"id":3420997,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-06T18:13:14.000Z","date":"2019-09-05","kind":"exercise","acquired":true,"shares":5000,"price":7.8,"value":39000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person executed a cash exercise of options without a subsequent sale of the underlying common stock."}],"balance_after":123167,"source":{"system":"sec-edgar","filing":"0001209191-19-048702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119048702/doc4.xml","form_type":"4"}},{"id":3620925,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T01:02:38.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":3213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":3213,"derivative":{"exercise_price":145.48,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":3213},"source":{"system":"sec-edgar","filing":"0001209191-19-016029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016029/doc4.xml","form_type":"4"}},{"id":3620924,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T01:02:38.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":118167,"source":{"system":"sec-edgar","filing":"0001209191-19-016029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016029/doc4.xml","form_type":"4"}},{"id":3777553,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T22:00:31.000Z","date":"2018-10-31","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.96,"expiration_date":"2019-03-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-056986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056986/doc4.xml","form_type":"4"}},{"id":3777552,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-02T22:00:31.000Z","date":"2018-10-31","kind":"sale","acquired":false,"shares":10000,"price":131.71,"value":1317100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.53 to $131.94, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein."}],"balance_after":116534,"source":{"system":"sec-edgar","filing":"0001209191-18-056986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056986/doc4.xml","form_type":"4"}},{"id":3777551,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-02T22:00:31.000Z","date":"2018-10-31","kind":"exercise","acquired":true,"shares":10000,"price":3.96,"value":39600.0,"ownership":{"direct":true},"balance_after":126534,"source":{"system":"sec-edgar","filing":"0001209191-18-056986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056986/doc4.xml","form_type":"4"}},{"id":4009158,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-03-07T23:01:50.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":4820,"derivative":{"exercise_price":71.45,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":4820},"source":{"system":"sec-edgar","filing":"0001209191-18-017788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017788/doc4.xml","form_type":"4"}},{"id":4009157,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T23:01:50.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":3418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock award represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":116534,"source":{"system":"sec-edgar","filing":"0001209191-18-017788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017788/doc4.xml","form_type":"4"}},{"id":4387333,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-15T01:45:34.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":12350,"derivative":{"exercise_price":32.63,"expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0001209191-17-020685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020685/doc4.xml","form_type":"4"}}],"next_cursor":"2017-03-15T01:45:34.000000Z,4387333"}